MWNA
HLTH

Marshall Wace North America’s Cue Health Inc. Common Stock HLTH Stock Holding History

Marshall Wace North America’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.16M Buy
+97,831
New +$1.54M ﹤0.01% 871

Other funds holding HLTH

KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $860M AUM 17.81% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
NCMU
NAYA Capital Management (UK) London, United Kingdom $1.18B AUM 13.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Marshall Wace North America's HLTH Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Cue Health Inc. Common Stock (HLTH) in Q3 2021: 97,831 shares worth $1.16M. The stake represents ﹤0.01% of the portfolio and ranks #871 among its holdings.

56 funds tracked by Wall St. Rank hold HLTH as of Q3 2021.

  • Marshall Wace North America held 97,831 shares of Cue Health Inc. Common Stock worth $1.16M as of Q3 2021.
  • Cue Health Inc. Common Stock was a new Marshall Wace North America position in Q3 2021.
  • Cue Health Inc. Common Stock made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #871 holding.
  • 56 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.